Status:
COMPLETED
Bright Light Therapy as Augmentation of Depressive Symptoms on Acute Psychiatric Floor
Lead Sponsor:
State University of New York - Upstate Medical University
Conditions:
Depression
Eligibility:
All Genders
18-90 years
Brief Summary
The purpose of this study is to explore if Bright Light Therapy (BLT) as augmentation of depression treatment on an acute psychiatric floor is feasible, helps alleviate depressive symptoms, improve fu...
Detailed Description
Background: Bright light therapy is an evidence-based treatment for seasonal depression (SAD), recently there is evidence that it has some efficacy in nonseasonal major depressive disorder (MDD) when...
Eligibility Criteria
Inclusion
- depressive symptoms on BDI (score 14 and above - eligible for BLT) and/or
- depressive symptoms on HAMD-17 (score 8 and above)
Exclusion
- no report of depressive symptoms; manic symptoms, acute psychosis, schizophrenia, schizoaffective disorder, impending Electro Convulsive Therapy (ECT), retinal risk factors, lupus, bright light sensitivity, glaucoma, cataracts, retinal detachment, retinopathy, patients on photosensitizing meds (tetracycline, sulfonamides, psoralens, and phenothiazine antipsychotics)
Key Trial Info
Start Date :
January 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 20 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04385394
Start Date
January 30 2020
End Date
August 20 2020
Last Update
October 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SUNY Upstate Medical University
Syracuse, New York, United States, 13210